C Staufner1, H J Blom2, C Dionisi-Vici3, P Freisinger4, N Makhseed5, D Ballhausen6, S Kölker1, G F Hoffmann1, I Harting7. 1. Department of General Pediatrics, Division of Neuropediatrics and Pediatric Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany. 2. Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany. 3. Division of Metabolism, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. 4. Children's Hospital Reutlingen, Reutlingen, Germany. 5. Department of Pediatrics, Jahra Hospital, Jahra, Kuwait. 6. Center for Molecular Diseases, CHUV Lausanne, Lausanne, Switzerland. 7. Department of Neuroradiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. inga.harting@med.uni-heidelberg.de.
Abstract
INTRODUCTION: Adenosine kinase deficiency (ADK deficiency) is a recently described disorder of methionine and adenosine metabolism resulting in a neurological phenotype with developmental delay, muscular hypotonia, and epilepsy as well as variable systemic manifestations. The underlying neuropathology is poorly understood. We have investigated MRI and (1)H-MRS changes in ADK deficiency in order to better understand the in vivo neuropathologic changes of ADK deficiency. METHODS: Systematic evaluation of 21 MRIs from eight patients (age range 9 days-14.6 years, mean 3.9 years, median 2.7 years) including diffusion-weighted imaging in six and (1)H-MRS in five patients. RESULTS: Brain maturation was delayed in the neonatal period and in infancy (6/6), but ultimately complete. White matter changes occurring in five of eight patients were discrete, periventricular, and unspecific (4/5), or diffuse with sparing of optic radiation, corona radiata, and pyramidal tracts (1/5). Choline was low in white matter spectra (3/3), while there was no indication of low creatine in white matter or basal ganglia (5/5), and diffusion was variably decreased or increased. Central tegmental tract hyperintensity was a common finding (6/8), as was supratentorial atrophy (6/8). CONCLUSIONS: MRI changes in ADK deficiency consist of delayed but ultimately completed brain maturation with later onset of mostly unspecific white matter changes and potentially transient central tegmental tract hyperintensity. Immaturity on neonatal MRI is consistent with prenatal onset of disease and reduced choline with lower membrane turnover resulting in delayed myelination and deficient myelin maintenance.
INTRODUCTION:Adenosine kinase deficiency (ADK deficiency) is a recently described disorder of methionine and adenosine metabolism resulting in a neurological phenotype with developmental delay, muscular hypotonia, and epilepsy as well as variable systemic manifestations. The underlying neuropathology is poorly understood. We have investigated MRI and (1)H-MRS changes in ADK deficiency in order to better understand the in vivo neuropathologic changes of ADK deficiency. METHODS: Systematic evaluation of 21 MRIs from eight patients (age range 9 days-14.6 years, mean 3.9 years, median 2.7 years) including diffusion-weighted imaging in six and (1)H-MRS in five patients. RESULTS: Brain maturation was delayed in the neonatal period and in infancy (6/6), but ultimately complete. White matter changes occurring in five of eight patients were discrete, periventricular, and unspecific (4/5), or diffuse with sparing of optic radiation, corona radiata, and pyramidal tracts (1/5). Choline was low in white matter spectra (3/3), while there was no indication of low creatine in white matter or basal ganglia (5/5), and diffusion was variably decreased or increased. Central tegmental tract hyperintensity was a common finding (6/8), as was supratentorial atrophy (6/8). CONCLUSIONS: MRI changes in ADK deficiency consist of delayed but ultimately completed brain maturation with later onset of mostly unspecific white matter changes and potentially transient central tegmental tract hyperintensity. Immaturity on neonatal MRI is consistent with prenatal onset of disease and reduced choline with lower membrane turnover resulting in delayed myelination and deficient myelin maintenance.
Authors: I Barić; M Cuk; K Fumić; O Vugrek; R H Allen; B Glenn; M Maradin; L Pazanin; I Pogribny; M Rados; V Sarnavka; A Schulze; S Stabler; C Wagner; S H Zeisel; S H Mudd Journal: J Inherit Metab Dis Date: 2005 Impact factor: 4.982
Authors: Magnus K Bjursell; Henk J Blom; Jordi Asin Cayuela; Martin L Engvall; Nicole Lesko; Shanti Balasubramaniam; Göran Brandberg; Maria Halldin; Maria Falkenberg; Cornelis Jakobs; Desiree Smith; Eduard Struys; Ulrika von Döbeln; Claes M Gustafsson; Joakim Lundeberg; Anna Wedell Journal: Am J Hum Genet Date: 2011-09-28 Impact factor: 11.025
Authors: Detlev Boison; Louis Scheurer; Valérie Zumsteg; Thomas Rülicke; Piotr Litynski; Brian Fowler; Sebastian Brandner; Hanns Mohler Journal: Proc Natl Acad Sci U S A Date: 2002-05-07 Impact factor: 11.205
Authors: S Harvey Mudd; Nancy Braverman; Martin Pomper; Kamer Tezcan; Jonathan Kronick; Parul Jayakar; Cheryl Garganta; Mary G Ampola; Harvey L Levy; Shawn E McCandless; Hobart Wiltse; Sally P Stabler; Robert H Allen; Conrad Wagner; Marlene W Borschel Journal: Mol Genet Metab Date: 2003-05 Impact factor: 4.797
Authors: Najmah Almuhsen; Simon-Pierre Guay; Marie Lefrancois; Cheryl Gauvin; Al Qasim Al Bahlani; Najma Ahmed; Christine Saint-Martin; Tommy Gagnon; Paula Waters; Nancy Braverman; D Buhas Journal: JIMD Rep Date: 2021-07-27